BBI Life Sciences

About:

BBI Life Sciences Corporation providers the life sciences research products and services industry.

Website: http://www.bbi-lifesciences.com/

Top Investors: Qiming Venture Partners

Description:

BBI Life Sciences Corporation is one of the leading providers with the widest portfolio coverage in the life sciences research products and services industry in China. Their comprehensive product and service portfolio for life sciences research has an extensive range of applications, including (i) DNA synthesis products, (ii) genetic engineering services, (iii) life sciences research consumables; and (iv) protein and antibody related products and services. Their customers include colleges and universities, research institutes, hospitals, pharmaceutical and biotech companies, government testing and diagnostic centres, as well as distribution companies in China and overseas. Moreover, their Sangon and BBI brands have become highly recognisable in the market based on product and service quality, price competitiveness, and express delivery services. In terms of revenue in 2013, they are the largest provider of DNA synthesis products in China, and also ranked first among oligonucleotide synthesis product providers as a sub-segment of DNA synthesis products.

Total Funding Amount:

$10.3M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2013-07-10

Contact Email:

enquiry(AT)sangon.com

Founders:

Qisong Wang

Number of Employees:

1001-5000

Last Funding Date:

2015-03-01

IPO Status:

Public

Industries:

© 2025 bioDAO.ai